SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-18-003584
Filing Date
2018-11-29
Accepted
2018-11-29 14:36:20
Documents
51
Period of Report
2018-08-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT cannabics_10k-083118.htm 10-K 649878
2 GRAPHIC image1.jpg GRAPHIC 46663
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, cannabics_10k-ex3101.htm EX-31.1 10608
4 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, cannabics_10k-ex3102.htm EX-31.2 10662
5 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER cannabics_10k-ex3201.htm EX-32.1 4139
6 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER cannabics_10k-ex3202.htm EX-32.2 4373
  Complete submission text file 0001683168-18-003584.txt   2250011

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE cnbx-20180831.xml EX-101.INS 314605
8 XBRL SCHEMA FILE cnbx-20180831.xsd EX-101.SCH 20460
9 XBRL CALCULATION FILE cnbx-20180831_cal.xml EX-101.CAL 36529
10 XBRL DEFINITION FILE cnbx-20180831_def.xml EX-101.DEF 49968
11 XBRL LABEL FILE cnbx-20180831_lab.xml EX-101.LAB 152605
12 XBRL PRESENTATION FILE cnbx-20180831_pre.xml EX-101.PRE 120916
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 000-52403 | Film No.: 181208072
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1